JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] --
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on August 26, 2005; DOI: 10.1124/jpet.105.089805


This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.105.089805v1
315/3/1237    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kocsis, P.
Right arrow Articles by Tarnawa, I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kocsis, P.
Right arrow Articles by Tarnawa, I.


Received for publication May 26, 2005.
Revised July 19, 2005.
Accepted for publication August 25, 2005.

Tolperisone-type drugs inhibit spinal reflexes via blockade of voltage gated sodium and calcium channels

Pal Kocsis 1, Sandor Farkas 1*, Laszlo Fodor 1, Norbert Bielik 1, Marta Than 1, Sandor Kolok 1, Aniko Gere 1, Monika Csejtei 1, Istvan Tarnawa 1

1 Pharmacological and Drug Safety Research, Gedeon Richter Ltd. H-1475, Budapest, 10, POB: 27, Hungary

* Address correspondence to: E-mail: s.farkas{at}richter.hu

Abstract

The spinal reflex depressant mechanism of tolperisone and some of its structural analogs with central muscle relaxant action was investigated. Tolperisone (50-400 µM), eperisone, lanperisone, inaperisone and silperisone (25-200 µM) dose-dependently depressed the ventral root potential of isolated hemisected spinal cord of 6-day-old rats. The local anesthetic lidocaine (100-800 µM) produced qualitatively similar depression of spinal functions in the hemicord preparation, while its blocking effect on afferent nerve conduction was clearly stronger. In vivo, tolperisone and silperisone as well as lidocaine (10 mg/kg, intravenously) depressed ventral root reflexes and excitability of motoneurons. However in contrast with lidocaine the muscle relaxant drugs seemed to have a more pronounced action on the synaptic responses than on the excitability of motoneurons. Whole-cell measurements in dorsal root ganglion cells revealed that tolperisone and silperisone depressed voltage gated sodium channel conductance at concentrations that inhibited spinal reflexes. Results obtained with tolperisone and its analogues in the [3H]-BTX binding in cortical, and in a fluorimetric membrane potential assay in cerebellar neurons further supported the view that blockade of sodium channels may be a major component of the action of tolperisone-type centrally acting muscle relaxant drugs. Furthermore tolperisone, eperisone and especially silperisone had a marked effect on voltage gated calcium channels, while calcium currents were hardly influenced by lidocaine. These data suggest that tolperisone-type muscle relaxants exert their spinal reflex inhibitory action predominantly via a presynaptic inhibition of the transmitter release from the primary afferent endings via a combined action on voltage gated sodium and calcium channels.


Key words: calcium channel, central muscle relaxant, sodium channel, spinal cord, spinal reflex, tolperisone





Home Help [Feedback] [For Subscribers] [Archive] [Search] --
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2005 by the American Society for Pharmacology and Experimental Therapeutics.